Rothera Mark

Average Profitability
19.88%
Insider Buys Quantity
4
Insider Buys Sum
$436,821.68
Insider Sells Quantity
13
Insider Sells Sum
$5.11M

Insider Activity of Rothera Mark

According to the SEC Form 4 filings, Rothera Mark, being in a position of

  1. President and CEO at Viracta Therapeutics, Inc.,
    оver the last 12 months, has bought 100000 shares for $49,362, and sold 0 shares,
    over all time since 2023-11-30, has bought 100000 shares for $49,362, and sold 0 shares.

The largest purchase of all time was on 2013-06-25 and amounted to 25000 shares of PTC Therapeutics, Inc. for $375,000.

The largest sale of all time was on 2015-02-23 and amounted to 23000 shares of PTC Therapeutics, Inc. for $1.5M.

Biography of Rothera Mark

No biography is available at this moment.

2023-12-01PurchaseViracta Therapeutics, Inc.
VIRX
President and CEO
47,906
0.1301%
$0.49$23,627+21.25%
2023-11-30PurchaseViracta Therapeutics, Inc.
VIRX
President and CEO
52,094
0.1374%
$0.49$25,734+16.92%
2016-03-03PurchasePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
2,000
0.006%
$6.23$12,460+31.23%
2015-03-17SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
10,700
0.032%
$76.64$820,048-54.53%
2015-03-13SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
300
0.0009%
$76.36$22,908-50.72%
2015-02-25SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
11,000
0.0332%
$73.49$808,390-48.17%
2015-02-24SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
1,000
0.0029%
$67.70$67,700-46.21%
2015-02-23SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
23,000
0.07%
$65.40$1.5M-40.89%
2015-01-20SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
3,000
0.0091%
$60.02$180,060-19.81%
2015-01-16SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
2,300
0.007%
$58.67$134,941-17.83%
2015-01-14SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
1,200
0.0037%
$58.62$70,344-14.91%
2015-01-13SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
8,500
0.026%
$57.96$492,655-14.38%
2014-09-26SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
3,000
0.0103%
$46.90$140,700+11.78%
2014-09-25SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
10,100
0.0343%
$44.38$448,225+16.46%
2014-09-24SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
2,900
0.0098%
$43.18$125,234+18.54%
2014-09-15SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
8,000
0.0271%
$36.24$289,910+41.97%
2013-06-25PurchasePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
25,000
0.0898%
$15.00$375,000+8.52%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.